EC Proposes Specific Clinical Trial Requirements For ATMPs
Executive Summary
A new EU draft guideline on clinical trials with ATMPs outlines a number of areas where specific requirements and safeguards might be needed when testing these often complex and novel products in humans.
You may also be interested in...
Thumbs Up For EU Guidance On Advanced Therapy Trials
New guidelines on good clinical practice for advanced therapies address the constraints most often encountered by developers conducting trials for these types of treatments.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.
EU Warns Of Life-Threatening Interactions Between Paxlovid & Some Immunosuppressants
The EU’s pharmacovigilance committee says that a review of the available evidence showed that in several cases, blood levels of immunosuppressants increased rapidly to toxic levels in patients who were taking the Pfizer drug.